Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report.

Abstract

BACKGROUND:

Sweet syndrome (SS) is characterized by sudden appearance of multiple, painful erythematous, papular-nodular skin lesions accompanied by a fever and myalgia. SS resembles Visphota (Bullous eruption disorders) in Ayurveda. SS is a scarcerare skin condition, and Ayurvedic management of this condition is not reported. Therefore, this case report is prepared after taking informed consent from the patient.

CASE PRESENTATION:

A 34-year-old male patient presented with a complaint of the appearance of multiple blisters over the upper and lower extremities, forehead, and chest with mild fever, congestion of the eye, joint pain, and muscular stiffness for the last two weeks. He has been on oral prednisolone for ten weeks by a dermatologist. The patient has no history of taking drugs in the previous four months before the onset of the skin lesions. The patient was prescribed Nagaradi Kasya (Amrttam Kasaya), Siddha Makardwaja (Plain), Kaisara Guggulu (KG), Ashwagandha ghana vati, and Avipatikar Churna in recommended dose for two weeks. Fifty percentage lesions disappear along systemic symptoms within seven days and complete remission of lesions in fifteen days. The medication was stopped after fifteen days and observed for one year. There is a significant reduction of inflammatory markers like-erythrocyte sedimentation rate (ESR), Total Leucocyte Count (TLC), and C Reactive protein (CRP) after the treatment compared to the baseline also.

CONCLUSION:

Ayurvedic modalities may be a better treatment option in rare skin conditions like sweet syndrome, where corticosteroid usage failed to improve. More evidence of the usefulness of the Ayurvedic therapeutic approach must be gathered.

• Authors: Ashok Kumar Panda, Krishna Rao S, Bikash Ranjan Kar, Sarbeswar Kar
• Journal: Journal of Ayurveda and integrative medicine (J Ayurveda Integr Med) 2023 May-Jun Vol. 14 Issue 3 Pg. 100709 ISSN: 0975-9476 [Print] United States
• PMID: 37253314 (Publication Type: Case Reports)
• Copyright: Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.